MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Clinical trial NCT04762875 · TERMINATED

Trial details

NCT number: NCT04762875
Sponsor: Ensoma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Related Donors Donating PBSC to a Family Member Healthy Donors Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome

Start date: 2021-06-16
Primary completion: 2021-09-14
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.